Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.
about
Opioid antagonists for alcohol dependenceThe role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical reviewUsing Ecological Momentary Assessment (EMA) to Assess Situation-Level Predictors of Alcohol Use and Alcohol-Related ConsequencesImproving clinical outcomes for naltrexone as a management of problem alcohol useMedications for unhealthy alcohol use: across the spectrum.Pharmacogenetics of OPRM1.A principal components analysis of the abbreviated Desires for Alcohol Questionnaire (DAQ).Ecological momentary assessment (EMA) in studies of substance usePlacebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time.A pharmacogenetic model of naltrexone-induced attenuation of alcohol consumption in rhesus monkeysCharacterizing subjective responses to alcohol among adolescent problem drinkersOPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.Pharmacogenetics of alcohol and alcohol dependence treatmentMeta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful?Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation.Relationship between momentary affect states and self-efficacy in adolescent smokersThe Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study.The DRD4 exon 3 VNTR polymorphism and addiction-related phenotypes: a review.Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation.Biobehavioral mechanisms of topiramate's effects on alcohol use: an investigation pairing laboratory and ecological momentary assessmentsPharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.Ambulatory monitoring in the genetics of psychosomatic medicine.Gender Considerations in Addiction: Implications for Treatment.An event-level investigation of hangovers' relationship to age and drinking.Effects of naltrexone and LY255582 on ethanol maintenance, seeking, and relapse responding by alcohol-preferring (P) rats.Cigarette smoking predicts differential benefit from naltrexone for alcohol dependence.Naltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.Naltrexone improves quit rates, attenuates smoking urge, and reduces alcohol use in heavy drinking smokers attempting to quit smoking.Variation in OPRM1 moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment.Subjective responses to alcohol consumption as endophenotypes: advancing behavioral genetics in etiological and treatment models of alcoholism.Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.Effects of naltrexone on cortisol levels in heavy drinkers.Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol.A pilot study of naltrexone and BASICS for heavy drinking young adults.Initial evidence of an association between OPRM1 and adolescent alcohol misusePolymorphisms of the mu-opioid receptor and dopamine D4 receptor genes and subjective responses to alcohol in the natural environment.The genetics of the opioid system and specific drug addictionsEffects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial.Effects of alcoholism typology on response to naltrexone in the COMBINE study.Understanding naltrexone mechanism of action and pharmacogenetics in Asian Americans via behavioral economics: a preliminary study.
P2860
Q24235797-A529284D-657C-4A93-A98D-25F1BA16D455Q24616528-F5DA4005-56EE-4B4B-848D-A3B7B08143BBQ26799855-69896881-1C6B-41E6-BB8C-CA18771CF466Q27021406-7BD4D983-7E99-4EC2-982B-CC9D5C1F785CQ27690692-E8B4A70F-2ECC-4CA8-B9EE-6054D5A84D27Q33568294-3EB70ACD-1082-4C89-9729-DAA8D516C22EQ33624918-7E734BC7-AE22-452F-91B6-C2B8825A103CQ33757038-1B05769B-F949-422D-978F-84A060534B4AQ33828162-BF8D8287-3ABD-44C7-ABC5-CC3BF32B8AFAQ33872457-2903B39B-0A00-4D36-87C9-6312353035F7Q33915640-1E56B114-8833-49FE-B8B5-94088D754360Q33921223-D051D6C6-7009-4E27-9EA9-A9260A169BDBQ34081709-D0F0CAC9-61F0-4523-8C8D-3925F97ABB04Q34306652-9FAB8CD1-DADB-4B86-8834-70E1E806873EQ34311649-3E10F37A-11D9-4F96-AD61-95F103A2F58EQ34602493-757B9A19-A6C1-4E27-88DF-76094A9535AAQ34689570-6347C2A1-F8EF-4C1F-AA94-D5B11C9165CBQ34972111-DD84DAC3-E97B-4B5E-A30D-60EC49DBF6EEQ34982437-AF13C1C3-1960-4BAB-B28D-F39D9A353B09Q35553786-8A394D05-9EDA-48AD-8324-FFEDD70CC8C3Q35622645-841E036B-4138-47AB-BBD1-3E0564C11E05Q36041596-530AB948-8493-4213-86F4-A648F11C9670Q36082618-CA6EAB2E-482E-4034-B9C9-0FE5F7EA6642Q36083472-1F5429AF-0F76-4FDD-8E03-B9367C567BF9Q36090024-028004D0-2CA0-411B-830E-490D455BE311Q36133717-8DF84691-58D2-4918-9202-B44B4319319DQ36223647-436A3B27-7D3C-46EC-BCA1-4276A8E270FDQ36263819-A3276B4F-F5EA-4A9E-B3E5-C18FF625E983Q36322822-44EA7493-F0B7-45B3-8713-FC98EF36EC47Q36436395-F0667B9D-09B2-4080-8180-01ABE131E89CQ36540015-30403BD9-E7F5-4B0B-9F61-1D74AA984682Q36863387-ECEF6452-F065-4339-BC2F-5CD8C35F3118Q36931792-A99363FE-9C65-4703-9C10-54687C9AAC85Q36939060-49281651-FB64-45AE-82FD-81CEB1069B3AQ36952699-CC6385E6-2550-4EEE-8BC3-680CCE7E5623Q36989434-539CDEBA-B9AC-4336-A4BA-38988146FB22Q37040492-151818B8-D961-46D5-8194-E5CF0C78DD52Q37059531-3381F829-FEEC-4291-BEA5-F370831A5B4BQ37060490-71644A45-2546-4AC8-9408-01849F2E721BQ37089324-C606A1D1-806E-4571-907D-3AB6ACFAAAE5
P2860
Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Moderators of naltrexone's eff ...... rs in the natural environment.
@en
Moderators of naltrexone's eff ...... rs in the natural environment.
@nl
type
label
Moderators of naltrexone's eff ...... rs in the natural environment.
@en
Moderators of naltrexone's eff ...... rs in the natural environment.
@nl
prefLabel
Moderators of naltrexone's eff ...... rs in the natural environment.
@en
Moderators of naltrexone's eff ...... rs in the natural environment.
@nl
P2093
P2860
P1476
Moderators of naltrexone's eff ...... rs in the natural environment.
@en
P2093
Chad J Gwaltney
Damaris J Rohsenow
David B Abrams
James MacKillop
Jean A Paty
Jennifer W Tidey
John E McGeary
Peter M Monti
Robert M Swift
Robert Miranda
P2860
P356
10.1111/J.1530-0277.2007.00545.X
P577
2007-11-20T00:00:00Z